Pantoprazol "Bluefish" 20 mg enterotabletter Danemarca - daneză - Lægemiddelstyrelsen (Danish Medicines Agency)

pantoprazol "bluefish" 20 mg enterotabletter

bluefish pharmaceuticals ab - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg

Pramipexol "Bluefish" 0,18 mg tabletter Danemarca - daneză - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "bluefish" 0,18 mg tabletter

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,18 mg

Pramipexol "Bluefish" 0,35 mg tabletter Danemarca - daneză - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "bluefish" 0,35 mg tabletter

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg

Pramipexol "Bluefish" 0,7 mg tabletter Danemarca - daneză - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "bluefish" 0,7 mg tabletter

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg

Xeomin 100 enheder pulver til injektionsvæske, opløsning Danemarca - daneză - Lægemiddelstyrelsen (Danish Medicines Agency)

xeomin 100 enheder pulver til injektionsvæske, opløsning

merz pharmaceuticals gmbh - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 100 enheder

Xeomin 200 enheder pulver til injektionsvæske, opløsning Danemarca - daneză - Lægemiddelstyrelsen (Danish Medicines Agency)

xeomin 200 enheder pulver til injektionsvæske, opløsning

merz pharmaceuticals gmbh - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 200 enheder

Xeomin 50 enheder pulver til injektionsvæske, opløsning Danemarca - daneză - Lægemiddelstyrelsen (Danish Medicines Agency)

xeomin 50 enheder pulver til injektionsvæske, opløsning

merz pharmaceuticals gmbh - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 50 enheder

Thiotepa Riemser Uniunea Europeană - daneză - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.